Treatment of acute ischemic stroke by minimally manipulated umbilical cord-derived mesenchymal stem cells transplantation: A case report
STRI (Stem Cell Treatment & Research Institute) Registered a US Patent for its Newly Elicited Pluripotent Stem Cell without Side Effects by Natural Compounds (nEPS)
[약업신문] 2019, 03.13
STRI (Stem Cell Treatment & Research Institute) Registered a US Patent for its Newly Elicited Pluripotent Stem Cell without Side Effects by Natural Compounds (nEPS)
It can be differentiated into all the tissues and organs… Applicable to the treatment of incurable diseases.
View Detail: https://www.yakup.com/news/index.html?mode=view&cat=12&nid=228143
Related posts
